Green Valley Pharmaceuticals
China - ShanghaiPharmaceutical
Focus: Green Valley Pharmaceuticals is a China-based pharmaceutical company focused on Alzheimer's disease treatment, with a pipeline anchored on GV-971 (Sodium Oligomannate). Limited public data on scale and market position.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Green Valley Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Green Valley Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
GV-971
Stable
Peak
Lead program in Phase 4 development; flagship asset for Alzheimer's indication with regulatory advancement signals.
Pipeline & Clinical Trials
Help build intelligence for Green Valley Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.